FDA: Some Ebola Patients Need To Get Placebo

There’s been a pretty fierce debate in public health circles over a pressing question: when testing drugs to treat Ebola virus or vaccines that might prevent infection, do we need to do randomized controlled trials in which some patients get placebo, or is Ebola — like some forms of cancer — so deadly that you can tell a drug is working just by giving it.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news